Literature DB >> 19056268

Characterization of a novel TYMP splice site mutation associated with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).

Jan-Willem Taanman1, Mariza Daras, Juliane Albrecht, Charles A Davie, Elizabeth A Mallam, John R Muddle, Mark Weatherall, Thomas T Warner, Anthony H V Schapira, Lionel Ginsberg.   

Abstract

Mitochondrial neurogastrointestinal encephalomyopathy is an autosomal recessive disorder caused by loss-of-function mutations in the thymidine phosphorylase gene (TYMP). We report here a patient compound heterozygous for two TYMP mutations: a novel g.4009G>A transition affecting the consensus splice donor site of intron 9, and a previously reported g.675G>C splice site mutation. The novel mutation causes exon 9 skipping but leaves the reading frame intact; however, TYMP protein was not detected by immunoblot analysis, suggesting that neither mutant allele is expressed as protein. The patient's fibroblasts showed gradual loss of the mitochondrial DNA-encoded subunit I of cytochrome-c oxidase, suggesting a progressive mitochondrial DNA defect in culture.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19056268     DOI: 10.1016/j.nmd.2008.11.002

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  12 in total

Review 1.  CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders.

Authors:  Michio Hirano; Caterina Garone; Catarina M Quinzii
Journal:  Biochim Biophys Acta       Date:  2012-01-18

Review 2.  Structural insight on processivity, human disease and antiviral drug toxicity.

Authors:  Y Whitney Yin
Journal:  Curr Opin Struct Biol       Date:  2010-12-24       Impact factor: 6.809

3.  Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): case report with a new mutation.

Authors:  Zeren Bariş; Tuba Eminoğlu; Buket Dalgiç; Leyla Tümer; Alev Hasanoğlu
Journal:  Eur J Pediatr       Date:  2010-06-29       Impact factor: 3.183

4.  A single mutation in human mitochondrial DNA polymerase Pol gammaA affects both polymerization and proofreading activities of only the holoenzyme.

Authors:  Young-Sam Lee; Kenneth A Johnson; Ian J Molineux; Y Whitney Yin
Journal:  J Biol Chem       Date:  2010-05-31       Impact factor: 5.157

Review 5.  Applying genomic and transcriptomic advances to mitochondrial medicine.

Authors:  William L Macken; Jana Vandrovcova; Michael G Hanna; Robert D S Pitceathly
Journal:  Nat Rev Neurol       Date:  2021-02-23       Impact factor: 42.937

6.  Biochemical abnormalities in a patient with thymidine phosphorylase deficiency with fatal outcome.

Authors:  Jaap A Bakker; Patrick Schlesser; Hubert J M Smeets; Baudouin Francois; Jörgen Bierau
Journal:  J Inherit Metab Dis       Date:  2010-02-12       Impact factor: 4.982

7.  Clinical and molecular characterization of a patient with mitochondrial Neurogastrointestinal Encephalomyopathy.

Authors:  Parham Habibzadeh; Mohammad Silawi; Hassan Dastsooz; Shima Bahramjahan; Shahrokh Ezzatzadegan Jahromi; Vahid Reza Ostovan; Majid Yavarian; Mohammad Mofatteh; Mohammad Ali Faghihi
Journal:  BMC Gastroenterol       Date:  2020-05-08       Impact factor: 3.067

Review 8.  Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far.

Authors:  Dario Pacitti; Michelle Levene; Caterina Garone; Niranjanan Nirmalananthan; Bridget E Bax
Journal:  Front Genet       Date:  2018-12-21       Impact factor: 4.599

9.  Mitochondrial Dysfunction may explain symptom variation in Phelan-McDermid Syndrome.

Authors:  Richard E Frye; Devin Cox; John Slattery; Marie Tippett; Stephen Kahler; Doreen Granpeesheh; Shirish Damle; Agustin Legido; Michael J Goldenthal
Journal:  Sci Rep       Date:  2016-01-29       Impact factor: 4.379

10.  Mitochondrial neurogastrointestinal encephalomyopathy: approaches to diagnosis and treatment.

Authors:  Bridget E Bax
Journal:  J Transl Genet Genom       Date:  2020-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.